Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks - Wikidata - awgldk - TriplyDB

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

http://www.wikidata.org/entity/Q26801423

about

Discovering Drugs for the Treatment of Ebola Virus.Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys.Macrocyclic peptide inhibitors for the protein-protein interaction of Zaire Ebola virus protein 24 and karyopherin alpha 5.Therapeutics Against Filovirus Infection.Treatment-focused Ebola trials, supportive care and future of filovirus care.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus Animal Models of Ebolavirus Infection

P2860

Q40039706-3F1E49BD-E4F5-42AD-8F5E-A1F356B7CD0A Q40045875-85C3C147-80A5-4F79-B01B-332BEAC9BBE6 Q40054337-F7EBFA22-9144-4B8A-ACF8-832C82A639A2 Q40144389-EE80641D-7BF6-4779-95FF-D7BA7CBBD373 Q47360326-7E949110-ECD0-449A-A27C-F5972A112653 Q56535662-9B0EB671-F652-49CD-A6AB-6DA9757178AE Q56541916-33AC0977-2ACB-4CF8-B9D3-9FD5BDA2CE55

P2860

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

http://www.wikidata.org/entity/Q26801423

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@ast

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@en

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@nl

type

label

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@ast

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@en

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@nl

prefLabel

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@ast

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@en

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@nl

P1433

Q26801423-1DF413EB-5F4F-4814-9440-95D2673B0BA1

P1476

Q26801423-05C265ED-FB2A-43A6-B0BF-3466655B3661

P2093

Q26801423-2449CB8B-B7D5-4591-BEFC-F50A86A36693

Q26801423-3AA2BA3F-55F3-4E90-92A6-553637206317

Q26801423-4EBF80C3-5CA4-482E-8982-53CE7EF6727E

P2860

Q26801423-011B6201-811B-49D8-A5CB-9B8C83AF9DDB

Q26801423-05B3F4B3-459F-4B5E-BCB4-FE9117B29902

Q26801423-099F4FD9-2718-42B1-982D-D945A4137B62

Q26801423-10AE0B10-32BD-4520-B62B-5628586FEA67

Q26801423-1203B6D1-F05F-487F-8A58-FCE44CBFE80E

Q26801423-130882D7-BCCD-49B2-8AE5-87D4D36C130B

Q26801423-17B030AB-6363-4B3F-97E2-9654E6F94A3F

Q26801423-1F49C46D-284E-4F81-8FDB-4C6FBB8A3E1A

Q26801423-23B8AF84-AEC9-4F86-A85C-30FD19E56658

Q26801423-2612034D-907B-41B8-B14C-0B02202BF302

P304

Q26801423-91F36E27-E749-41E0-A39B-17EC08095450

P31

Q26801423-2EE7DB30-8BAA-4B69-861E-9267D26EDC30

P356

Q26801423-A50A35CC-835F-4104-84AF-1872172A997E

P407

Q26801423-5595C1B8-BABD-4CFC-9444-7366EBD2DBE1

P433

Q26801423-1645D156-150A-4D40-8B9A-6F26D0000075

P478

Q26801423-07D83530-7510-4835-9451-CBBE944B0609

P577

Q26801423-36B658D9-BC38-4424-83C0-884276147F18

P698

Q26801423-DFE90CFE-2FD3-4773-B574-DE91435AA0F4

P921

Q26801423-B1CA9BF7-725A-4D81-B410-16B26C28B404

P932

Q26801423-FAD508D9-515F-4409-83F2-4C40CB3C42C8

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks

@en

P2093

Azizul Haque

http://www.w3.org/2001/XMLSchema#string

Didier Hober

http://www.w3.org/2001/XMLSchema#string

Joel Blondiaux

http://www.w3.org/2001/XMLSchema#string

P2860

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis

A systematic screen of FDA-approved drugs for inhibitors of biological threat agents

Intracellular events and cell fate in filovirus infection

Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak

Ebola virus entry requires the cholesterol transporter Niemann-Pick C1

Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells

FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.

Emerging targets and novel approaches to Ebola virus prophylaxis and treatment

Confronting potential influenza A (H5N1) pandemic with better vaccines

Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs

P304

5892-902

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01105-15

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26248374

http://www.w3.org/2001/XMLSchema#string

P921

P932

4576072

http://www.w3.org/2001/XMLSchema#string